First Time in Human Study Using GSK2330672

Status:
Completed

Trial end date:
2011-09-09

Target enrollment:

Participant gender:

The purpose of this study is to look at the safety and tolerability of increasing single doses of GSK2330672 in healthy volunteers.

Phase 1

GlaxoSmithKline